Detalles de la búsqueda
1.
Extended-duration antibiotics are not associated with a reduction in surgical site infection in patients with ovarian cancer undergoing cytoreductive surgery with large bowel resection.
Gynecol Oncol
; 186: 161-169, 2024 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38691986
2.
Laparoscopic predictability of minimally invasive interval debulking in advanced ovarian cancer: The MIID-SOC trial.
Gynecol Oncol
; 185: 143-147, 2024 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38417209
3.
Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial.
Cancer
; 129(12): 1846-1855, 2023 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37060236
4.
Efficacy and toxicity of carboplatin and gemcitabine administered on day 1 and day 8 (day1&8) versus day 1-only for platinum-sensitive recurrent epithelial ovarian cancer.
Int J Gynecol Cancer
; 33(7): 1090-1098, 2023 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37024239
5.
A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer.
Int J Gynecol Cancer
; 33(9): 1458-1463, 2023 09 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37666539
6.
Incidence and prognostic significance of inguinal lymph node metastasis in women with newly diagnosed epithelial ovarian cancer.
Gynecol Oncol
; 165(1): 90-96, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35272875
7.
What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (≥10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer.
Gynecol Oncol
; 166(3): 410-416, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35835612
8.
Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study.
Am J Obstet Gynecol
; 227(1): 61.e1-61.e18, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35216968
9.
Impact of treatment modality on overall survival in women with advanced endometrial cancer: A National Cancer Database analysis.
Gynecol Oncol
; 160(2): 405-412, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33221023
10.
Impact of antibiotic treatment on immunotherapy response in women with recurrent gynecologic cancer.
Gynecol Oncol
; 161(1): 211-220, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33504455
11.
Development and validation of a comprehensive clinical risk-scoring model for prediction of overall survival in patients with endometrioid endometrial carcinoma.
Gynecol Oncol
; 163(3): 511-516, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34607712
12.
Modified frailty index predicts postoperative complications in women with gynecologic cancer undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Gynecol Oncol
; 162(2): 368-374, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34083027
13.
Patterns of recurrence in women with advanced and recurrent epithelial ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Gynecol Oncol
; 161(2): 389-395, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33551202
14.
Anastomotic leak following interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in women with advanced epithelial ovarian Cancer.
Gynecol Oncol
; 162(3): 645-651, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34247768
15.
Assessing feasibility and perioperative outcomes with minimally invasive surgery compared with laparotomy for interval debulking surgery with hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancer.
Gynecol Oncol
; 160(1): 45-50, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33067001
16.
Impact of intra-operative factors upon peri-operative outcomes in women undergoing hyperthermic intraperitoneal chemotherapy for gynecologic cancer.
Gynecol Oncol
; 161(1): 194-201, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33468319
17.
Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study.
Gynecol Oncol
; 161(1): 113-121, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33541735
18.
PARP inhibitors decrease response to subsequent platinum-based chemotherapy in patients with BRCA mutated ovarian cancer.
Anticancer Drugs
; 32(10): 1086-1092, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34520432
19.
Surgical lymph node assessment influences adjuvant therapy in clinically apparent stage I endometrioid endometrial carcinoma, meeting Mayo criteria for lymphadenectomy.
J Surg Oncol
; 123(5): 1292-1298, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33592112
20.
Perioperative outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in elderly women with epithelial ovarian cancer: analysis of a prospective registry.
Int J Gynecol Cancer
; 31(7): 1021-1030, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34006567